Selecting the most informative positive and negative controls for self-controlled case series (SCCS): Rationale, approach, and lessons from studies investigating the safety of COVID-19 vaccines.
作者信息
Rudan Igor, Katikireddi Srinivasa Vittal, Kerr Steven, Millington Tristan, Grange Zoe, Sullivan Christopher, Fagbamigbe Adeniyi Francis, Swallow Ben, Kurdi Amanj, Morrison Kirsty, Jeffrey Karen, Simpson Colin R, Ritchie Lewis, Robertson Chris, Sheikh Aziz
机构信息
Usher Institute, The University of Edinburgh, Edinburgh, UK.
Algebra University College, Zagreb, Croatia.
出版信息
J Glob Health. 2024 Aug 6;14:03037. doi: 10.7189/jogh.14.03037.
Abstract
摘要
相似文献
1
Selecting the most informative positive and negative controls for self-controlled case series (SCCS): Rationale, approach, and lessons from studies investigating the safety of COVID-19 vaccines.为自我对照病例系列（SCCS）选择最具信息性的阳性和阴性对照：原理、方法以及来自调查新冠病毒疫苗安全性研究的经验教训。
J Glob Health. 2024 Aug 6;14:03037. doi: 10.7189/jogh.14.03037.
2
A propensity score approach and a partitioned approach for the self-controlled case series design to evaluate safety of a 2-dose vaccine series: application to myocarditis/pericarditis following mRNA COVID-19 vaccination.一种倾向评分方法和一种用于自我对照病例系列设计以评估两剂疫苗系列安全性的分区方法：应用于mRNA新冠疫苗接种后的心肌炎/心包炎
Am J Epidemiol. 2025 Jan 8;194(1):254-266. doi: 10.1093/aje/kwae141.
3
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.临床试验中 SARS-CoV-2 疫苗的免疫原性和安全性。
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1286-1304. doi: 10.52586/5024.
4
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.新冠病毒疫苗接种后和 SARS-CoV-2 阳性检测后的血小板减少症和血栓栓塞风险：自身对照病例系列研究。
BMJ. 2021 Aug 26;374:n1931. doi: 10.1136/bmj.n1931.
5
Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study.意大利 COVID-19 疫苗接种后急性阑尾炎：一项自身对照病例系列研究。
Drug Saf. 2024 Nov;47(11):1157-1169. doi: 10.1007/s40264-024-01462-0. Epub 2024 Jul 27.
6
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
7
Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.新冠疫苗接种、SARS-CoV-2 感染与免疫介导的神经系统事件风险的关联：基于人群的队列和自身对照病例系列分析。
BMJ. 2022 Mar 16;376:e068373. doi: 10.1136/bmj-2021-068373.
8
Myocarditis Temporally Associated With COVID-19 Vaccination.心肌炎与 COVID-19 疫苗接种相关。
Circulation. 2021 Aug 10;144(6):502-505. doi: 10.1161/CIRCULATIONAHA.121.055891. Epub 2021 Jun 16.
9
Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.为什么持续存在的不确定性不是推迟冠状病毒疫苗挑战试验的理由。
J Med Ethics. 2020 Dec;46(12):808-812. doi: 10.1136/medethics-2020-106501. Epub 2020 Jul 13.
10
Risk of major adverse cerebro-cardiovascular events following BNT162b2, CoronaVac, and ChAdOx1 vaccination and SARS-CoV-2 infection: A self-controlled case-series study.BNT162b2、科兴新冠疫苗和牛津阿斯利康疫苗接种以及感染新冠病毒后发生重大不良心脑血管事件的风险：一项自我对照病例系列研究。
Vaccine. 2024 Dec 2;42(26):126465. doi: 10.1016/j.vaccine.2024.126465. Epub 2024 Oct 23.
引用本文的文献
1
BNT162b2 COVID-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5-11 years in Scotland.苏格兰5至11岁儿童和青少年接种BNT162b2新冠疫苗的情况、安全性、有效性及免疫效果减弱情况
J Glob Health. 2025 Aug 29;15:04250. doi: 10.7189/jogh.15.04250.
本文引用的文献
1
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.英格兰 510 万儿童接种 COVID-19 疫苗和感染后的安全结果。
Nat Commun. 2024 May 27;15(1):3822. doi: 10.1038/s41467-024-47745-z.
2
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study.英格兰第一剂和第二剂 COVID-19 疫苗接种后的不良事件：全国疫苗监测平台自身对照病例系列研究。
J R Soc Med. 2024 Apr;117(4):134-148. doi: 10.1177/01410768231205430. Epub 2023 Nov 3.
3
The State of Use and Utility of Negative Controls in Pharmacoepidemiologic Studies.药物流行病学研究中阴性对照的使用和实用性状况。
Am J Epidemiol. 2024 Feb 5;193(3):426-453. doi: 10.1093/aje/kwad201.
4
Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.BNT162b2和ChAdOx1第二剂接种后的血小板减少、血栓栓塞和出血事件：英国国家哨点队列的自我对照病例系列分析
Lancet Reg Health Eur. 2023 Jul 18;32:100681. doi: 10.1016/j.lanepe.2023.100681. eCollection 2023 Sep.
5
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study.2020 年 10 月至 2021 年 9 月期间，英格兰首次和第二次接种 COVID-19 疫苗后的不良事件：全国疫苗监测平台自身对照病例系列研究。
Euro Surveill. 2023 Jan;28(3). doi: 10.2807/1560-7917.ES.2023.28.3.2200195.
6
BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12-17 years in Scotland.苏格兰12至17岁儿童和青少年接种BNT162b2新冠疫苗的情况、安全性、有效性及抗体衰减情况
Lancet Reg Health Eur. 2022 Sep 28;23:100513. doi: 10.1016/j.lanepe.2022.100513. eCollection 2022 Dec.
7
Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales.接种 COVID-19 疫苗后出现血小板减少症、出血和血栓栓塞性疾病以及阳性检测结果的风险：威尔士的一项自身对照病例系列分析。
Sci Rep. 2022 Sep 30;12(1):16406. doi: 10.1038/s41598-022-20118-6.
8
Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.苏格兰第二剂 ChAdOx1 和 BNT162b2 COVID-19 疫苗接种与血小板减少性、血栓栓塞性和出血性事件。
Nat Commun. 2022 Aug 15;13(1):4800. doi: 10.1038/s41467-022-32264-6.
9
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.在退伍军人健康管理局中，加强针与 2 剂 mRNA COVID-19 疫苗接种的相对有效性：自我对照风险间隔分析。
Vaccine. 2022 Aug 5;40(33):4742-4747. doi: 10.1016/j.vaccine.2022.06.047. Epub 2022 Jun 21.
10
The self-controlled case series method and covid-19.自我对照病例系列法与新冠疫情
BMJ. 2022 Apr 6;377:o625. doi: 10.1136/bmj.o625.
Zotero 插件